- Initial data from the ongoing Phase 1b study evaluating R289, a dual IRAK1/4 inhibitor, in LR-MDS Initial data from the dose escalation phase using a July 15, 2024 data cutoff date indicate that ...

allowing for control of tumors in vivo without the need for exogenous or engineered cytokines- - Posters include demonstration of advances in gene editing and transgene design that enable greater ...

Maximize the impact of your visual presentations with these tips ... You don't have to format visuals from scratch. PowerPoint has premade slide templates with spots for images, graphs, tables and ...

These customizable PowerPoint templates are ... you may adjust the template as needed, but do not stretch or modify the master brand mark or crest within the template. Print your poster on campus. For ...

Streamline your presentation ... PowerPoint templates. Looking to include general information on some of the university’s biggest points of pride? Add any or all of these pre-made slides to your deck ...

All Environmental Studies majors participate in public poster presentations as part of the thesis process. A poster session is organized for Wednesday in the last week of the fall and winter semesters ...

The posters were not created or installed by the ... urging passersby to "Keep NYC Trash Free." The accompanying illustrations of what constituted "trash" showed people wearing "Make America ...

PRAGUE & BASEL, Switzerland & BOSTON--(BUSINESS WIRE)--SOTIO Biotech, a clinical-stage immuno-oncology company owned by PPF Group, today announced it will present three posters at the 2024 Society for ...

today announced that a poster detailing the use of the Company’s Magellan platform to discover novel allosteric discoidin domain receptor 2 (DDR2) inhibitors will be presented at the 36 th EORTC ...

RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today ...